Angiotensin II antagonists
- 1 April 2006
- journal article
- Published by Wiley in Nephrology
- Vol. 11 (s1) , S92-S97
- https://doi.org/10.1111/j.1440-1797.2006.00617.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2004
- Standards of Medical Care in DiabetesDiabetes Care, 2004
- The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 DiabetesNew England Journal of Medicine, 2001
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathyKidney International, 2000
- Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathyKidney International, 2000